Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. - Wikidata - awgldk - TriplyDB

Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.

Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.

http://www.wikidata.org/entity/Q37110229

about

The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference Reproducibility of dynamically represented acoustic lung images from healthy individuals.Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies Exercise pathophysiology and the role of oxygen therapy in idiopathic interstitial pneumonia Respiratory disease and respiratory physiology: putting lung function into perspective interstitial lung disease The peripheral blood transcriptome identifies the presence and extent of disease in idiopathic pulmonary fibrosis Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.Idiopathic pulmonary fibrosis in Saudi Arabia: Demographic, clinical, and survival data from two tertiary care hospitals MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study [18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis.Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis Impact of serum SP-A and SP-D levels on comparison and prognosis of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema.The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.Pulmonary function impairment in patients with combined pulmonary fibrosis and emphysema with and without airflow obstruction.Idiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis.miR-210 promotes IPF fibroblast proliferation in response to hypoxia.Cardiorespiratory responses to 6-minute walk test in interstitial lung disease: not always a submaximal test.The value of CT for disease detection and prognosis determination in combined pulmonary fibrosis and emphysema (CPFE).Desaturation - distance ratio: a new concept for a functional assessment of interstitial lung diseases Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD Pirfenidone treatment of idiopathic pulmonary fibrosis.Clinical relevance of plasma prostaglandin F2α metabolite concentrations in patients with idiopathic pulmonary fibrosis.Utility of the 6-minute walk test following lung transplantation.Severity classification for idiopathic pulmonary fibrosis by using fuzzy logic Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma.TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis.Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis.The Microbiome and the Respiratory Tract Interstitial lung abnormalities and reduced exercise capacity.Cardiopulmonary exercise testing in lung transplantation: a review.Cyclooxygenase-2 deficiency exacerbates bleomycin-induced lung dysfunction but not fibrosis Distance saturation product predicts health-related quality of life among sarcoidosis patients.The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.Heart rate response to a timed walk and cardiovascular outcomes in older adults: the cardiovascular health study.Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots.Outcome Measures for Clinical Trials in Interstitial Lung Diseases.Determinants of 6-minute walk distance in patients with idiopathic pulmonary fibrosis undergoing lung transplant evaluation.

P2860

Q24628952-46E1DFD0-FC33-4CC7-B3FF-8AC8BF315223 Q24649002-6659B28C-0761-4E0D-9619-1462DB60BDDF Q26747694-1748A2D4-2A86-4099-B329-BC18603F0C85 Q26749492-239A8F27-A7B4-445E-AE0E-CB88F565E1FF Q26785390-F73459D1-1F4D-4949-B706-4452A2BA114E Q27001599-172BD26E-D078-4755-B2DD-B7FE6C5E8911 Q28728072-437E3360-F58F-437D-BF5E-F996EE09AD15 Q30415751-B2ADE846-18AA-45EB-9EE8-4B5F1F69AFD1 Q30834669-7D7D960C-95C3-4B98-9AF1-F91ED71F2BC6 Q30983821-80B41037-C260-4702-BF92-9FDE37940A6B Q33612767-12A19EA0-5FFB-4B99-8A40-29316071861D Q33652974-C5FA63A7-A5FB-4D89-8DED-4D21D276E6A4 Q33783426-A6E643B8-5CA7-4C34-B436-61139A6766B0 Q33788227-A099D799-3E23-42D3-B60B-C71ADE0CF20C Q33855641-3E2368B3-1B35-430B-A288-5706A7117A54 Q33905090-16D9F6A6-AC96-412C-889D-D13ACD980D83 Q34005618-B24E4D4F-DFAB-4A62-8A16-9216BF62471E Q34026607-539AE663-A6C7-48DA-A714-F8047C92E72C Q34062979-293296E7-9845-4D5C-974A-817060547B12 Q34071333-ED89603A-F265-4032-A078-6A0DDC7CB994 Q34156210-B01700D6-D3BB-4EAE-9993-076931B9FF5A Q34197933-13481D6F-BE2F-4B36-9B2C-DB5EBAC75E69 Q34471290-5BD46757-E4C9-49E8-96C3-AFB8F1BA0197 Q34574174-33E9E35E-A882-4FF5-BCCD-279B7337644E Q34776159-976C39BA-784D-438B-A3A9-CD3378AF01F0 Q34986258-D5CDABB5-7679-415C-A7DF-4FF980CB4993 Q35087202-B838CBA9-E05C-46EB-8F00-9B1141CFA157 Q35112333-25ECF748-DCCD-439B-82F0-9F0142099074 Q35606977-2BF49594-898B-43D2-A340-44077F1BD52D Q35610196-DDBB23C6-D7AF-43AA-975A-14F70BC35535 Q35829947-F2CD2C6C-4FAD-4CEA-95E1-B230D779A0D5 Q35889148-3FA218B7-B961-4309-A3E2-AD97EA127EB1 Q35991326-632ACBC9-E496-4A20-9DDF-2D192120EA52 Q36013692-5AE4BB9A-6FCC-491D-ABD0-39B98887665C Q36130247-94A738A4-C256-4D38-B809-F12BC42F8424 Q36231734-38D9B156-54D4-4E5D-B473-4EC9EC206F54 Q36451082-B69F47AF-4B1D-47E0-B240-C86A44046C26 Q36719113-4AC98361-3386-4C7C-BDD8-E3BBDBAD2512 Q36726418-383B8726-8A0C-4AA4-B75D-91EB10ADD5FD Q36734220-605AAA6C-6746-4157-8F0F-63FA24F455FB

P2860

Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.

http://www.wikidata.org/entity/Q37110229

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 July 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Idiopathic pulmonary fibrosis: ...... logy and six-minute-walk test.

@en

Idiopathic pulmonary fibrosis: ...... logy and six-minute-walk test.

@nl

type

label

Idiopathic pulmonary fibrosis: ...... logy and six-minute-walk test.

@en

Idiopathic pulmonary fibrosis: ...... logy and six-minute-walk test.

@nl

prefLabel

Idiopathic pulmonary fibrosis: ...... logy and six-minute-walk test.

@en

Idiopathic pulmonary fibrosis: ...... logy and six-minute-walk test.

@nl

P1433

Q37110229-170B22DF-37F9-462A-92BE-CD72CB60EF33

P1476

Q37110229-F8755EEA-9101-4EC1-AF2F-A3BF6155BD65

P2093

Q37110229-0C6AA53D-5EFF-466F-97F1-6C0AE4264D52

Q37110229-0E12F147-B818-47F7-AE90-5E13FAF70ECD

Q37110229-474B4C31-9FDC-415D-8815-C2D9450D1265

Q37110229-52FD9228-5537-4E9F-9AC8-F18D9A7984CE

Q37110229-5DFDA7B4-BD1E-4C89-A736-03F1931A2592

Q37110229-8E56427C-B078-465B-8323-AC6675E39C1D

Q37110229-AB08AF42-A2F6-433E-8D41-41546747B1A0

Q37110229-C4431681-FEAF-4A4D-AD2F-4F69BCE25A26

Q37110229-EC6CAAAE-63CC-4AB4-8B92-58898E283F7F

P2860

Q37110229-06104ED8-06DF-462A-8BE9-84432F755065

Q37110229-1D8CE180-27C4-4DDF-9280-0FCC6C7E7ED3

Q37110229-1DBCB382-A924-49D0-9D56-689FD71E3140

Q37110229-272BBBDB-4B83-44E1-94D9-248B24D60B3F

Q37110229-29FC4A11-B4DD-4B79-8795-F015C954CFFC

Q37110229-2ED5EC7F-38CE-4097-B745-D07EE3410798

Q37110229-4104196B-4EA9-49BB-88A1-7559AEDAD5DE

Q37110229-518E4EDA-BA59-415E-B306-DFDE85C2B51F

Q37110229-52B13BCA-3A13-4B48-8FDC-5AB31FF6CF51

Q37110229-550288B6-E4D2-47B7-964C-88FA0BBEA378

P304

Q37110229-2CD4F9DD-988E-45AC-815F-787787098C7F

P31

Q37110229-26692627-1D1B-4769-9C92-3A1A3DD7D73A

P356

Q37110229-A091CFCC-8E2E-446C-B630-0D306E3312D9

P407

Q37110229-56EEA06D-170E-49CD-A61D-D0ACE3587F19

P433

Q37110229-075D7247-7347-40B4-B0D9-2731ABF74058

P478

Q37110229-384136A6-8D6A-487F-B02E-F0678EB0E191

P50

Q37110229-26A7489A-4E00-41BB-9051-5E9C65590526

Q37110229-A80134BD-A21A-40EE-B8B3-7C02FE3587D6

P577

Q37110229-DF4642B7-F8A8-4B4E-8633-D6FA28493101

P5875

Q37110229-16968EA4-A31A-4A50-93D4-3E8577A6C69E

P698

Q37110229-16DE54B9-B9AB-4E29-A5B3-AD536490702D

P921

Q37110229-88D7094D-837D-4E42-950B-D0A2BD7B13D7

P932

Q37110229-E41999E0-80A5-43CB-8525-16858A28B00D

P356

RCCM.200604-488OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Idiopathic pulmonary fibrosis: ...... ology and six-minute-walk test

@en

P2093

Barry H Gross

http://www.w3.org/2001/XMLSchema#string

Chris Fraley

http://www.w3.org/2001/XMLSchema#string

Ella A Kazerooni

http://www.w3.org/2001/XMLSchema#string

Fernando J Martinez

http://www.w3.org/2001/XMLSchema#string

Galen B Toews

http://www.w3.org/2001/XMLSchema#string

Kevin R Flaherty

http://www.w3.org/2001/XMLSchema#string

Thomas V Colby

http://www.w3.org/2001/XMLSchema#string

Vibha Lama

http://www.w3.org/2001/XMLSchema#string

William D Travis

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model.

The clinical course of patients with idiopathic pulmonary fibrosis.

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Radiological versus histological diagnosis in UIP and NSIP: survival implications.

Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.

Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.

Lung function estimates in idiopathic pulmonary fibrosis: the potential for a simple classification.

Clinical significance of histological classification of idiopathic interstitial pneumonia.

P304

803-809

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200604-488OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P50

Adin-Cristian Andrei

P577

2006-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6958977

http://www.w3.org/2001/XMLSchema#string

P698

16825656

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

2648064

http://www.w3.org/2001/XMLSchema#string